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ABSTRACT 
A STUDY COMPARING OUTCOMES OF APPENDECTOMY BETWEEN 
HIV-INFECTED AND HIV-NEGATIVE PATIENTS  
Authors: Sanju Sobnach, Delawir Kahn  
Affiliations: Department of Surgery & Division of General Surgery, Groote Schuur 
Hospital & University of Cape Town, Anzio Road, Observatory 7925, Cape Town, 
Republic of South Africa.  
Background: The high prevalence of Human Immunodeficiency Virus (HIV) has 
added a new dimension to the management and outcomes of many general surgical 
conditions in South Africa. However, there is a paucity of data describing the impact 
of HIV status on surgical outcomes in our setting. Appendicitis is the most common 
gastrointestinal emergency, and its surgical outcomes in areas of high HIV prevalence 
are poorly described in the literature. Thus, the aim of this study is to describe and 
compare the outcomes of appendectomy between HIV-infected (HIV+) and HIV-
negative (HIV-) patients.  
Methods: This is a retrospective study of patients undergoing appendectomy at a 
large regional hospital over a 12-month period. Demographic data, duration of pre-
hospital symptoms, HIV status, surgical approach, operative findings, histopathology 
reports, hospital stay and complications were recorded. Data for the HIV+ and HIV- 
patient cohorts were then described, analysed and compared. Statistical analysis was 
performed using the Chi-Squared or Fisher’s exact test for non-continuous variables, 
and non- parametric ANOVA and Wilcoxon ranked sum test for continuous variables. 
A P-value less than 0·05 was considered statistically significant.  
Results: The study group comprised 134 patients; 18 (13.4 %) tested positive for 
HIV. HIV+ patients were significantly older (mean age of 29.3 vs. 20.3 years, P= 
0.002) and had longer duration of pre-hospital symptoms (mean of 3.94 vs. 2.57 days, 
P= 0.03). Postoperative complications (44.4 % vs. 17.2 %, P= 0.03) and lengthier 
hospital stays (7.28 days vs. 5.95 days, P= 0.004) were also more frequently seen in 
the HIV+ patients. There were no differences in appendiceal rupture rates, 
histopathological findings and mortality.  
Conclusion: HIV infection is common in patients admitted with clinical features of 
acute appendicitis in South Africa. Presentation in HIV+ patients was delayed, and 
surgery was associated with significant postoperative morbidity and longer hospital 
stay. 
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CHAPTER ONE: 
LITERATURE REVIEW 
1.1 Introduction 
The Human Immune Deficiency Virus/Acquired Immune Deficiency Syndrome 
(HIV/AIDS) pandemic has added a new dimension to the epidemiology, clinical 
presentation and outcomes of a wide array of surgical conditions in South Africa. [1-7] 
The surgical abdomen in the HIV-infected (HIV+) patient requires more than the 
standard armamentarium of the general surgeon because of its increased morbidity 
and mortality, particularly in the latter stages of the disease. [3,6,8-13] South Africa has 
the highest HIV prevalence worldwide; 6.4 million people are infected with the virus. 
[14] This has further translated into local surgical cohorts; HIV is now the most
prevalent comorbid disease and is present in 13.2% of patients undergoing surgery in 
South Africa. [15]  
Despite this ravaging pandemic, there is a paucity of published South African data 
describing and investigating the relationship between HIV and common general 
surgical conditions. [3,6,16-18] Acute appendicitis is one of the most common 
Gastrointestinal (GIT) surgical emergencies in South Africa. [19-22] Its surgical 
management thus presents an interesting platform to study the effect of HIV on the 
surgical outcomes of a common general surgical intervention. 
1.2 The Human Immune Deficiency Virus 
HIV is a member of the retrovirus family; seven distinct genera of retroviruses exist. 
HIV type 1 (HIV-1) and HIV type 2 (HIV-2) belong to the genus of lentiviruses. Both 
types are transmitted mainly through unprotected sexual intercourse, but HIV-2 is less 
pathogenic and confined to West Africa. Whilst the origins of HIV remain 
controversial, it is well established that HIV-1 is predominantly responsible for the 
global epidemic. [23-25]  
The HIV has a complex structure. It has an outer viral envelope and a central viral 
core. The viral envelope is derived from the host cell plasma membrane and contains 
a docking glycoprotein 120 (gp120) and a transmembrane glycoprotein 41(gp41). The 
principal components of the viral core include two copies of the HIV genome in the 
form of Ribonucleic Acid (RNA), protein p7 and three enzyme proteins (Reverse 
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Transcriptase, Protease and Integrase), which are required for replication. CD4+ 
helper T lymphocytes, monocyte/macrophage lineages and cells expressing CCR5 or 
CXCR4 receptors are primarily affected by HIV. Other target cells include microglial 
cells in the central nervous system, dendritic cells in the mucosa and the renal 
epithelium. The virus enters the target cell by binding its viral envelope gp120 to the 
CD4 receptor (Figure 1). [26] Within the cell cytoplasm, viral RNA is then reverse 
transcribed into a double stranded complementary Deoxyribonucleic Acid (DNA) by 
the enzyme reverse transcriptase. This complementary pro-viral DNA is inserted into 
the host chromosome through a series of DNA cutting and joining reactions. [26-35]  
Figure 1. Early phase of HIV-1 replication [26] 
Typically, HIV enters the host through the genital tract mucosa after unprotected 
sexual intercourse. [24] It crosses the mucosal and submucosal spaces, and is picked up 
by the antigen-presenting dendritic cells via Dendritic Cell-Specific Intercellular 
adhesion molecule-3-Grabbing Non-integrin (DC-SIGN). The dendritic cells migrate 
to the regional lymph nodes and present the virus to an abundant population of CD4+ 
helper T lymphocytes. Four to 11 days after the initial infection, the virus 
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disseminates to the lymphoid tissues of the body through the bloodstream. This phase 
is characterised by a high viremia, which clinically manifests as an episodic flu-like 
illness. Early mucosal replication occurs mainly in the GIT, where the bulk of CD4+ 
helper T lymphocytes are housed in Gut Associated Lymphoid Tissue (GALT). HIV 
replication is accompanied by a profound consumption of CD4+ helper T lymphocytes 
in GALT. Low levels of T lymphocytes persist despite Highly Active Antiretroviral 
Therapy (HAART), in contrast to peripheral blood CD4+ counts which normalise with 
treatment. [36-40] 
Untreated infection progresses to AIDS. [26-28] Early diagnosis, uninterrupted medical 
care and HAART remain the three most important pillars in the management of the 
HIV+. [29-34] The Centers for Disease Control and Prevention (CDC) has generated 
HIV/AIDS case definitions and classification systems for surveillance, and clinicians 
often refer to them when describing patients’ clinical and immune statuses. The 
updated 2014 CDC case definitions for HIV infection stage patients based on their 
CD4 counts and clinical evidence of AIDS-defining conditions (Table 1). [41]  
Table 1: 2014 CDC Case definitions for HIV infection in adolescents and adults [41] 
It is also more flexible and allows for a patient’s stage to be up-staged or down-staged 
after the initial diagnosis. This is in stark contrast to the previous CDC classification 
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which permanently classified patients according to the most advanced stage of disease 
experienced, irrespective of their clinical progress following treatment. [42]  
Although the future of HIV research looks promising, prospects of a vaccine remain 
elusive. [29] This is partly due to the persistence of the virus in a latent form in resting 
memory CD4+ T cells, which are very stable and persist for years despite HAART.
Fortunately, the roll out of HAART programs has markedly improved life expectancy 
in patients. [30-33]
HAART is currently recommended in those with an AIDS-defining condition 
regardless of CD4+ count or when it drops below 200 cells/l. Recently, there has 
been a paradigm shift regarding the criteria to initiate HAART; a treat all policy 
irrespective of CD4+ count and clinical stage is the new therapeutic strategy. [34] 
1.3 Epidemiology of Human Immune Deficiency Virus infection in South Africa 
Thirty-seven million people are infected with HIV worldwide, the majority of whom 
(25.8 million) are from Sub-Saharan Africa. South Africa has the highest number of 
people living with HIV globally; the national prevalence is 12% and 6.4 million 
people live with the disease. There is a significantly higher number of women 
infected with the virus and young individuals belonging to the 30 to 34-year age 
group are the most affected (Figure 2). [14] 
Figure 2. HIV prevalence by sex and age in South Africa [14] 
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Residents of rural informal areas are at higher risk of getting infected, with KwaZulu-
Natal being the top high prevalence province in South Africa at 16.9%. Our study was 
conducted in the Northern Cape province, where the HIV prevalence is 7.4%. [14,30,32]
South Africa currently boasts the largest HAART program in the world. Three million 
patients are on treatment and the annual intake includes a further 600 000. Improved 
life expectancy with HAART and the increasing HIV prevalence in South Africa over 
the past decade are both significant contributors to an epidemiological transition 
witnessed by surgeons. [14,30,43,44] The latter now frequently manage long term 
sequelae of HIV infection such as GIT lymphoma, abdominal Tuberculosis (TB), 
Kaposi’s Sarcoma (KS) and HIV vasculopathy, as well as the complications of 
HAART-induced pancreatitis and lipodystrophy. [9,45-49] This epidemiological 
transition has also translated in medical and surgical cohorts across the country. HIV 
is the second most common chronic disease in South Africa after hypertension (Table 
2). [14,50-52] 
Table 2: Prevalence of chronic medical conditions in South Africa [14,50-52] 
Chronic Medical Condition Prevalence in South Africa (%) 
Hypertension 30.4 
HIV 12.2 
Asthma 8.1 
Diabetes 7.0 
In the large multi-centre prospective South African Surgical Outcomes Study, Biccard 
et al showed that HIV/AIDS was present in 13.2% of patients undergoing surgery in 
South Africa (Table 3). [15]  
Table 3: Comorbid conditions in patients recruited for South African Surgical 
Outcomes Study [15] 
Comorbid disease N (%) 
HIV/AIDS 509 (13.2) 
Chronic Obstructive Pulmonary Disease/Asthma 240 (6.2) 
Diabetes 225 (5.8) 
Coronary Artery Disease 160 (4.1) 
Congestive Cardiac Failure 55 (1.4) 
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1.4 Appendicitis in South Africa 
The vermiform appendix is embryologically derived from the midgut. It is a worm-
shaped tubular structure originating from the posteromedial caecal wall at the junction 
of the taeniae, and averages 9 cm in length. Arterial supply is via the appendicular 
artery, a branch of the ileocolic artery. Venous drainage is through the ileocolic veins 
and the right colic vein into the portal vein via the superior mesenteric vein. [53] The 
appendix contains lymph follicles and an epithelial lining coated with 
immunoglobulins, which assist with lymphatic surveillance. [54] 
Appendicitis is a very common GIT surgical emergency. [55] Inflammation and 
swelling of the appendix result from proliferation of intestinal bacteria within the 
lumen. White blood cells are recruited and pus formation causes further pressure 
build-up. This is followed by wall ischaemia, necrosis and subsequent rupture of the 
appendix. Diffuse peritonitis will ensue followed by septic shock and death. [56-58] 
Although the aetiology of appendicitis is still debatable, luminal obstruction by a 
faecolith remains a widely accepted theory. [54] 
The definitive surgical management of appendicitis in South Africa is appendectomy. 
Antibiotics as first-line therapy for uncomplicated acute appendicitis is feasible but 
should be considered with a great degree of caution in our setting. The recurrence rate 
of appendicitis is 26% within the first year [59-61] Many South African patients still 
live in rural areas, where difficult access to hospitals and delay to definitive surgical 
care lead to more frequent post-operative morbidity and mortality. [19,21,22,62] An early 
appendectomy at the initial presentation therefore remains the approach of choice and 
must be regarded as lifesaving in South Africa.   
A rising incidence of appendicitis is being reported in developing nations. [55] This has 
been attributed to societal and environmental factors that are associated with 
industrialisation, and include low dietary fibre intake, smoking and air pollution. [63-66] 
South African data suggest that 10% of the Caucasian population have undergone 
surgery for acute appendicitis, but less than 1% of Africans had undergone the same 
procedure. This racial disparity is explained by the consumption of a low fat and high 
fibre diet amongst certain racial groups. [67]   Male patients were more likely to have 
surgery for acute appendicitis and had higher rates of perforation than women. A 
recent systematic review conducted by Yang et al confirmed that appendicitis trends 
in South Africa are consistent with those seen in other newly industrialised countries. 
[19] However, appendicitis in South Africa has a far more serious clinical course when
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compared to developed countries, mainly because of the longer delays required to 
receive definitive surgical care. A high perforation rate of 36% and the need for 
laparotomy in 18% to 60% of patients are factors that drive the high post-operative 
morbidity seen in these patients. [19,21] Up to 30% of patients will require Temporary 
Abdominal Closure (TAC) at their initial surgery because of four quadrant peritonitis, 
diffuse soiling of the abdomen and the need for relook laparotomies. Furthermore, 
11% of patients will require admission to the Intensive Care Unit (ICU) and 29% will 
require a second surgical intervention. [22]  
1.5 The Surgical abdomen in the Human Immune Deficiency Virus-infected 
patient 
GIT complaints of diarrhoea, weight loss and malnutrition are well described in 
patients infected with HIV-1. In healthy adults, GIT immunity is maintained by 
Mucosal Associated Lymphoid Tissue (MALT). It is the largest mammalian lymphoid 
organ system and harbours 80% of all immune cells. Immune T cells and B cells 
migrate from MALT foci located in the intestine and appendix to effector sites, where 
pathogens and pathogen-laden cells are eliminated.  
Figure 3: Chronic HIV infection causes microbial translocation and immune 
activation. (a)Normal bowel epithelium, (b) Chronic HIV infection [36] 
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The virus disrupts the intestinal immune system, with resultant bacterial translocation 
and systemic immune activation. It has also been recently established that alterations 
in the gut microbiota contribute to further mucosal damage and endotoxemia (Figure 
3). [36]  
The HIV pandemic has altered the practice of surgery; 20% to 25% of all HIV+ 
patients will need some form of surgery during their lifetime. [68] Earlier initiation of 
HAART and improved long term survival of HIV+ patients mean that surgeons may 
manage pathologies related to chronic HIV infection, complications of HAART, as 
well as surgical problems common to the general population (Table 4). [30-34,68,69]
Table 4. Causes of abdominal pain in HIV+ patients [30-34,68,69] 
Surgical Infections Immunological Drug induced 
Appendicitis Mycobacterium 
avium complex 
Lymphoma Pancreatitis 
Peptic ulcer disease Cytomegalovirus Kaposi’s sarcoma Indinavir-induced 
renal calculi 
Diverticulitis Microsporidia Malignant 
obstruction 
Gastritis 
Cholecystitis Tuberculosis 
Hepatitis 
Mesenteric ischaemia 
Abdominal aortic 
aneurysm 
Abdominal pain is a common ailment; 10% to 15% of HIV+ patients will experience 
a severe episode at least once during the course of their illness. Establishing whether 
patients need conservative therapy coupled with further investigations versus urgent 
surgical intervention is often a challenge for the general surgeon in South Africa. [70-
75] The complexities lie primarily with the interpretation of conflicting findings and
investigations, and a high incidence of opportunistic infections. Moreover, emergency 
surgery in the AIDS patient is associated with significant morbidity and mortality.
[3,4,6,16] The most common indications for surgery in the HIV+ patient are detailed in 
Table 5. [72] 
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Table 5. Indications for abdominal surgery in HIV+ patients [72] 
Indications for surgery Aetiology 
Acute appendicitis 
Faecolith, Lymphoid hyperplasia, Kaposi’s sarcoma, 
Cytomegalovirus, Tuberculosis 
Bowel Perforation Lymphoma, Disseminated Tuberculosis, Cytomegalovirus 
GIT obstruction Lymphoma, Disseminated Tuberculosis, Kaposi’s sarcoma 
Toxic megacolon Cytomegalovirus, Clostridium difficile infection 
Cholecystitis Acute acalculous type, AIDS related 
Splenomegaly AIDS, Trauma, Abscess 
The impact of the HIV pandemic on surgical outcomes remains controversial;  
there are no prospective trials in the current literature and most retrospective studies 
are small and yielded conflicting results. [9-12,16-18] Early reports showed high mortality 
rates of 55% to 70% in AIDS patients undergoing emergency surgery. Based on the 
data available then, surgeons tended to be more conservative with HIV+ patients and 
avoided major surgical interventions. [76,77] However, there is now emerging evidence 
to suggest that the post-operative morbidity and mortality in HIV+ patients compare 
favourably to HIV- patients, and that the standard surgical therapy should be equally 
afforded to both groups. [16-18,78]
The main limitation of the old studies was that most investigators failed to make a 
clear distinction between the surgical risk in HIV+ patients and AIDS patients. This 
argument has been well substantiated by Harris et al [76], who showed that when an 
AIDS-related condition is the primary indication for emergency surgery, the 
morbidity increases by four-fold and the mortality rises from 15% to 44%. However, 
more than two thirds of HIV+ patients who undergo abdominal surgery for an acute 
abdomen do not have any AIDS-related pathology. Therefore, the data cannot be used 
to guide the standard of surgical care for all HIV+ patients. [79,80]
Studies investigating the relationship between HIV status and GIT surgery outcomes 
have yielded contradictory data with regards to morbidity, mortality and hospital stay. 
[6-12] Intra-abdominal malignancy is associated with a high incidence of wound 
breakdown. [13] Anorectal procedures are also predisposed to poorer outcomes, and 
late mortality is related to the progression of HIV infection rather than the primary 
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surgical pathology. [81] Irrespective of aetiology, GIT bleeding is a poor 
prognosticator of both in-hospital and long-term mortality.  [82,83]  
Following major abdominal surgery, HIV+ patients should be considered for ICU 
care. In a South African study, Bhagwanjee et al [84] showed no increase in the ICU 
and total hospital stay, albeit the higher incidence of septic shock in HIV+ patients. 
Predictors of long-term survival after ICU admission include mechanical ventilation 
and albumin levels. [85] 
Establishing whether CDC clinical stage or CD4+ count are prognosticators after 
abdominal surgery in the HIV+ has been a futile endeavour so far; the literature 
comprises mainly of retrospective series with conflicting results. [6,10,11,16,86] Some 
studies showed higher morbidity with advanced clinical stages of the disease [80,81], 
whilst others showed no difference. [87-89]  
CD4+ count is still regarded by many as a valid predictor of outcome in HIV+ patients 
undergoing abdominal surgery. CD4+ helper T lymphocytes are important role players 
in the initial infection with the virus and play a vital role in wound healing. [28,29,38,39]
Many surgeons still advocate a CD4+ count >200 cells/l before operating on an 
infected patient. [16]. In a prospective cohort study, ČaČala et al [17] showed that HIV 
status did not influence the outcome of general surgical procedures, and CD4+ count 
was not a prognosticator of total hospital stay, hospital mortality and severity of post-
operative sepsis. However, in a recent large retrospective study investigating the 
effects of HIV status on the outcomes of surgical sepsis, Green et al [6] determined 
that there was a significantly higher mortality of 60% in patients who had a CD4+ 
count <200 cells/l versus 2% in the CD4+ count >200 cells/l group. In emergency 
surgery patients, a lower CD4+ count is associated with increased post-operative 
septic complications and longer hospital stay [10]. Xia et al [11] have gone on to further 
suggest that a CD4/CD8 ratio 0.15 is a useful predictor of post-operative sepsis in 
HIV+ patients undergoing major abdominal surgery. 
Early immunological restoration with HAART will be therapeutic strategy chosen by 
clinicians in the future. [34] HAART controls the disease progression by suppressing 
the viral load [30-33]. This would theoretically lead to better operative outcomes in 
those undergoing abdominal surgery. [16]
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1.6 Appendicitis in the Human Immune Deficiency Virus-infected patient  
Appendicitis is a global disease. [55] Baker et al [90] described the first case of 
appendicitis in a HIV+ patient in 1986. The early medical literature is limited to case 
reports describing HIV-related opportunistic infections such as TB, KS and 
Cytomegalovirus as aetiological agents of appendicitis. [91-94] A rising incidence of 
appendicitis in the developing world has been partly attributed to the HIV/AIDS 
crisis. [55,95] HIV+ patients are more susceptible to developing appendicitis; the 
incidence of appendicitis is three to four-fold higher than in the general population.
[73,95] There are a number of postulates for this observation. The high incidence of 
associated opportunistic infections seen with HIV and the fragile appendiceal 
vasculature have certainly impacted upon the aetiology and epidemiology of 
appendicitis. [3,6,73,95,96] Aldeen et al [71] hypothesised that acute appendicitis could be a 
manifestation of the Immune Reconstitution Inflammatory Syndrome (IRIS) after the 
initiation of HAART. The restoration of lymphatic tissue architecture through 
hyperplasia and B-cell stimulation within the appendix account for the 
pathophysiology of appendicitis in these cases. HAART agents such as Indinavir may 
also be responsible for the formation of appendiceal abscesses. [71,73] The last theory 
pertains to the massive T-cell depletion that occurs early in the GIT despite HAART. 
It is associated with dysbiosis of microbiota, increased gut permeability and bacterial 
translocation. [36-40,97]  
Appendicitis is a common surgical emergency in the HIV+ patient. [3,70-74,78,98-102]
In a large cohort of patients at a South African hospital, Green et al [6] showed that 
appendicitis was the cause of surgical sepsis in 26% of HIV+ patients. The diagnosis 
of appendicitis in the HIV+ patient remains challenging. Opportunistic infections like 
TB and AIDS-related malignancies such as KS and lymphoma will frequently mimic 
the clinical presentation of appendicitis. Whilst an appendectomy will assist the 
surgeon in confirming the diagnoses and direct further therapy, the associated post-
operative morbidity and mortality have raised concerns. [3,6-13,98,101,102]
The effect of HIV infection on appendicitis and the surgical outcomes thereof have 
not been studied enough; there are only six published reports in the current literature. 
[3,78,98,100-102] Paradoxically, only two of these reports are from Sub-Saharan Africa 
where HIV is highly prevalent. [3,101] The studies addressing surgical outcomes of 
appendicitis in HIV+ and HIV- patients are summarised in Table 6.    
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Table 6: Studies addressing surgical outcomes of appendicitis in HIV+ and HIV- patients 
Study Year Country 
Period 
(years) 
Number of 
patients 
Significant Study findings 
Bova et al [100] 1998 Australia 10 
HIV- (60) 
HIV+ (26) 
Significant delay in presentation to hospital in the HIV+ group 
Higher post-operative morbidity rate in HIV+ group 
Giiti et al [101] 2010 Tanzania 1 
HIV- (173) 
HIV+ (26) 
HIV+ patients older and have less leukocytosis 
Peritonitis more common in HIV+ group with increased rates of 
Surgical Site Infection and lengthier hospital stay 
Masoomi et al 
[102]
2015 US 3 
HIV- (572444) 
HIV+ (800) 
Patients with AIDS had lengthier hospital stay, higher post-operative 
complication and mortality rates 
Laparoscopic appendectomy in AIDS patients has lower morbidity, 
mortality and shorter hospital stay compared to open appendectomy 
Kitaoka et al [98] 2015 Japan 6 
HIV- (212) 
HIV+ (6) 
CD4+ count lower in HIV+ patients with complicated appendicitis 
Gigabhoy et al 
[3]
2016 
South 
Africa 
1 
HIV- (36) 
HIV+ (14) 
Higher laparotomy rate in HIV+ patients 
Smith et al [78] 2016 US 8 
HIV- (337514) 
HIV+ (794) 
Longer and more expensive hospital stay in AIDS patients 
Higher risk of post-operative infections in AIDS patients 
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The prevalence of HIV in patients undergoing appendectomy in Sub-Saharan Africa 
is not negligible. Gigabhoy et al [3] recently showed that the HIV prevalence in 
patients undergoing appendectomy at King Edward VIII Hospital in Durban is 28%. 
In a Tanzanian study conducted at a major referral centre, the prevalence was found to 
be 13.1%. [101] These findings support the theory suggesting that HIV status may be a 
risk factor for appendicitis. [3,6,71,73,95,96] HIV+ patients presenting with appendicitis are 
also older than their seronegative counterparts. A large study that interrogated the 
Nationwide Inpatient Sample (NIS) in the US showed that AIDS patients undergoing 
appendectomy were significantly older than the control group. [78] These findings are 
echoed in both papers emanating from Africa. [3,101]  
Failure to mount an immune response can manifest clinically by the absence of 
pyrexia and abdominal signs in early appendicitis. Two studies have convincingly 
shown that pre-operative leukocytosis is seen less frequently in HIV+ patients. [100,101]   
Localised right iliac fossa tenderness is not common in those infected with the virus, 
and 57% of these patients have peritonitis on presentation. [3] The absence of these 
clinical signs explains the significant delay to hospital presentation, and the 
subsequent high post-operative morbidity and mortality that ensue. A higher 
laparotomy rate in these patients is also ascribed to the high perforation rates and 
peritonitis that occur secondary to delays in presentation. [3,78,100,101] Most studies 
show that there is a higher incidence of post-operative complications and a lengthier 
hospital stay in the HIV+ group. [78,98,100-102] The morbidity relates predominantly to 
Surgical Site Infections, and is less commonly seen when a laparoscopic approach is 
used. [102]
It is still not clear whether CD4+ count, Viral Load (VL) and clinical stage influence 
the surgical outcomes of appendectomy in HIV+ patients. The CD4+ count is low in 
patients with appendiceal perforation and those undergoing laparotomy [3,6] Although 
a decreased viral load is associated with a decreased occurrence of appendicitis [95], 
there is currently no evidence to show that it can be used as a reliable post-operative 
prognosticator. The interrogation of large databases to elucidate whether HIV status 
influences surgical outcomes of appendectomy is only helpful to a certain extent. This 
is because data is extracted via the International Statistical Classification of Diseases 
and Related Health Problems (ICD) system. Individual patient characteristics such as 
CD4+ count, CD4/CD8 ratio, VL and the presence of opportunistic infections are not 
easily gathered and therefore cannot be analysed. [78,102]  
23 
The current data does provide some direction regarding the issue, but there is a need 
for a large multi-centre prospective study in Sub-Saharan Africa to investigate the 
effect of HIV status on the surgical outcomes of appendicitis.  
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ABSTRACT 
Background: The high prevalence of Human Immunodeficiency Virus (HIV) has 
added a new dimension to the management and outcomes of many general surgical 
conditions in South Africa. However, there is a paucity of data describing the impact 
of HIV status on surgical outcomes in our setting. Appendicitis is the most common 
gastrointestinal emergency, and its surgical outcomes in areas of high HIV prevalence 
are poorly described in the literature. Thus, the aim of this study is to describe and 
compare the outcomes of appendectomy between HIV-infected (HIV+) and HIV-
negative (HIV-) patients. 
Methods: This is a retrospective cohort study of patients undergoing appendectomy at 
a large regional hospital over a 12-month period. Demographic data, duration of pre-
hospital symptoms, HIV status, surgical approach, operative findings, histopathology 
reports, hospital stay and complications were recorded. Data for the HIV+ and HIV- 
patient cohorts were then described, analysed and compared. 
Results: The study group comprised 134 patients; 18 (13.4 %) tested positive for HIV. 
HIV+ patients were significantly older (mean age of 29.3 vs. 20.3 years, P= 0.002) 
and had longer duration of pre-hospital symptoms (mean of 3.94 vs. 2.57 days, P= 
0.03). Postoperative complications (44.4 % vs. 17.2 %, P= 0.03) and lengthier 
hospital stays (7.28 days vs. 5.95 days, P= 0.004) were also more frequently seen in 
the HIV+ patients. There were no differences in appendiceal rupture rates, operative 
approaches, histopathological findings and mortality.  
Conclusion: HIV infection is common in patients admitted with clinical features of 
acute appendicitis in South Africa. Presentation in HIV+ patients was delayed, and 
surgery was associated with significant postoperative morbidity and longer hospital 
stay.  
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Introduction 
The Human Immune Deficiency Virus/Acquired Immune Deficiency Syndrome 
(HIV/AIDS) pandemic has added a new dimension to the epidemiology, clinical 
presentation and outcomes of a wide array of surgical conditions in South Africa. [1-7]  
Thirty-seven million people are infected with HIV worldwide, the majority of whom 
(25.8 million) live in Sub-Saharan Africa. South Africa has the highest number of 
people living with HIV globally; the national prevalence is 12% and 6.4 million 
people live with the disease. Residents of rural informal areas are at higher risk of 
getting infected, with KwaZulu-Natal being the top high prevalence province in South 
Africa at 16.9%. Our study was conducted in the Northern Cape province, where the 
HIV prevalence is 7.4%. [8]
South Africa currently boasts the largest Highly Active Antiretroviral Therapy 
(HAART) program in the world. Three million patients are on treatment and the 
annual intake includes a further 600 000. Improved life expectancy with HAART and 
the increasing HIV prevalence in South Africa over the past decade are both 
significant contributors to an epidemiological transition witnessed by surgeons. [8-14] 
The latter now frequently manage the longterm sequelae of HIV infection such as 
Gastrointestinal (GIT) lymphoma, abdominal Tuberculosis (TB), Kaposi’s Sarcoma 
(KS) and HIV vasculopathy, as well as the complications of HAART-induced 
pancreatitis and lipodystrophy. [15-19] This epidemiological transition has also 
translated in medical and surgical cohorts across the country. HIV is the second most 
common chronic disease in South Africa after hypertension (Table 1). [20-24] In the 
large multi-centre prospective South African Surgical Outcomes Study, Biccard et al 
showed that HIV/AIDS was present in 13.2% of patients undergoing surgery in South 
Africa (Table 2). [25]  
Abdominal pain is a common complaint; 10% to 15% of HIV-infected (HIV+) 
patients will experience a severe episode at least once during the course of their 
illness. Establishing whether patients need conservative therapy coupled with further 
investigations versus urgent surgical intervention is often a challenge for the general 
surgeon in South Africa. [26] The complexities lie primarily with the interpretation of 
conflicting findings and investigations, and a high incidence of opportunistic 
infections. Moreover, emergency surgery in the AIDS patient is associated with 
significant morbidity and mortality. [27-30]  
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Appendicitis is a global disease. [34] Baker et al [35] described the first case of 
appendicitis in a HIV+ patient in 1986. The early medical literature is limited to case 
reports describing HIV-related opportunistic infections such as TB, KS and 
Cytomegalovirus as aetiological agents of appendicitis. [36-39] A rising incidence of 
appendicitis in the developing world has been partly attributed to the HIV/AIDS 
crisis. [40] HIV+ patients are more susceptible to developing appendicitis; the 
incidence of appendicitis is three to four-fold higher than in the general population. [26] 
There are a number of postulates for this observation. The high incidence of 
associated opportunistic infections seen with HIV and the fragile appendiceal 
vasculature have certainly impacted on the aetiology and epidemiology of 
appendicitis. [40] Aldeen et al [41] hypothesised that acute appendicitis could be a 
manifestation of the Immune Reconstitution Inflammatory Syndrome (IRIS) after the 
initiation of HAART. The restoration of lymphatic tissue architecture through 
hyperplasia and B-cell stimulation within the appendix account for the 
pathophysiology of appendicitis in these cases. HAART agents such as Indinavir may 
also be responsible for the formation of appendiceal abscesses. [40] The last theory 
pertains to the massive T-cell depletion that occurs early in the GIT despite HAART. 
It is associated with dysbiosis of microbiota, increased gut permeability and bacterial 
translocation. [42]  
Appendicitis is a common surgical emergency in the HIV+ patient. [3,31,43-47]  
In a large cohort of patients at a South African hospital, Green et al [6] showed that 
appendicitis was the cause of surgical sepsis in 26% of HIV+ patients. The diagnosis 
of appendicitis in the HIV+ patient remains challenging. Opportunistic infections like 
TB and AIDS-related malignancies such as KS and lymphoma will frequently mimic 
the clinical presentation of appendicitis. Whilst an appendectomy will assist the 
surgeon in confirming the diagnoses and direct further therapy, the associated post-
operative morbidity and mortality have raised concerns. [43-47]
The effect of HIV infection on appendicitis and the surgical outcomes thereof have 
not been studied enough; there are only six published reports in the current literature. 
[3,31,43,45-47] Paradoxically, only two of these publications are from Sub-Saharan Africa 
where HIV is highly prevalent. [3,46] The studies addressing surgical outcomes of 
appendicitis in HIV+ and HIV- patients are summarised in Table 3. The aim of this 
study is to describe and compare the outcomes of appendectomy between HIV-
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infected (HIV+) and HIV-negative (HIV-) patients in a setting where HIV is 
significantly prevalent. 
Patients and Methods 
The Human Research Ethics Committee of the Faculty of Health Sciences at the 
University of Cape Town granted ethical approval for this study (HREC REF: 
341/2015). Patients subjected to appendectomy following a clinical diagnosis of acute 
appendicitis from March 2010 to March 2011 at Kimberley Provincial Hospital were 
included in this retrospective study. Standard demographic information, time from 
onset of symptoms to hospital admission, HIV status, medical comorbidities, details 
of surgical approach, operative findings, histopathology reports, duration of Intensive 
Care Unit (ICU) admission, total hospital stay and post operative complications were 
documented. When a patient was known to be HIV-infected, the CD4+ count and the 
HAART regimen were recorded. 
Surgical approach 
Following initial assessment, a clinical diagnosis of acute appendicitis and informed 
consent, patients were taken for surgery. Prophylactic antibiotics were administered in 
all cases. Patients with localised right iliac fossa tenderness were approached through 
a McBurney or Lanz incision. An exploratory midline laparotomy was performed for 
generalized peritonitis. At the time of this study, laparoscopy had been newly 
introduced at Kimberley Provincial Hospital; laparoscopic appendectomy was thus 
attempted only in a limited number of cases. Conversion from a McBurney incision, 
Lanz incision or a laparoscopic approach to a laparotomy was necessary when diffuse 
peritonitis was noted intraoperatively or when the appendectomy could not be 
completed safely through the initial surgical approach. All resected appendices were 
sent for histopathological assessment.   
Post operative care and follow up  
Antibiotics were stopped within 48 hours of appendectomy for uncomplicated 
appendicitis and continued for five days in cases of rupture or diffuse peritonitis. HIV 
testing was offered to all patients; pre-test and post-test counseling were conducted 
irrespective of the test result. In the event of a positive result, the patient was 
immediately referred to the Infectious Diseases Clinic.  On discharge from hospital, 
all patients were entered into a four-week follow-up program, and issued with a 
summary note detailing medical problems, treatment administered and a list of 
instructions to be followed. In particular, patients were advised to return to the unit 
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immediately in the event of persistent abdominal pain, pyrexia and wound sepsis. 
Readmitted patients underwent complete clinical, biochemical and radiological 
evaluation as necessary. 
Statistical analysis was performed using the Chi-Squared or Fisher’s exact test for 
non-continuous variables, and non- parametric ANOVA and Wilcoxon ranked sum 
test for continuous variables. A P value less than 0·05 was considered statistically 
significant. 
Results  
One hundred and thirty-nine patients were subjected to appendectomy from March 
2010 to March 2011. Five patients were excluded from the study; three did not 
consent to HIV testing and two had incomplete medical records.  
The study sample thus comprised 134 patients. There were 86 males (64.2 %) and 48 
females with a mean age of 21.5 years (range: 4 – 64). Eighteen patients were HIV+; 
16 were diagnosed during the present hospital admission and two patients were 
known to be HIV+ on HAART. A CD4+ count was available in 13 of these 16 
patients; the mean count was 260 cells/μL (range: 12 – 1129). HIV+ patients were 
older (mean age of 29.3 years vs. 20.3 years, P = 0.002) and experienced symptoms 
for longer (mean of 3.94 days vs. 2.57 days, P = 0.03) before presenting to hospital 
(Table 4). There was no difference in the signs and symptoms experienced by both 
patient groups (Table 5). 
A laparotomy was more frequently performed in the HIV+ patient (72.2% vs. 41.3%, 
P =0.03) (Table 6). The postoperative complication rate was higher in HIV+ patients 
(44.4% vs. 17.2 %, P = 0.03); the predominant complication was Surgical Site 
Infection (SSI) (Table 7). There was no difference in the mortality. Although the total 
hospital stay was longer for HIV+ patients (7.28 days vs. 5.95 days, P= 0.004), ICU 
stay was similar in both patient groups.  
The appendiceal perforation rates and negative appendectomy rates were similar in 
the HIV+ and HIV- groups, 38.9% vs. 31.0% (P=0.69) and 27.8% vs. 12.9% (P=0.20) 
respectively.  
Discussion 
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The HIV/AIDS pandemic has significantly impacted upon the South African surgical 
landscape. Atypical presentations and outcomes associated with increased morbidity 
and mortality are now well recognized amongst many general surgical conditions. [1-7]  
This study was conducted in the Northern Cape province of South Africa, where the 
HIV prevalence is 7.4%. An HIV seroprevalence of 13.4% in this cohort of patients is 
not negligible and is comparable to data from other Sub-Saharan centres. Gigabhoy et 
al [3] recently showed that the HIV prevalence in patients undergoing appendectomy at 
a large tertiary urban hospital is 28%. In a Tanzanian study conducted at a major 
referral centre, the prevalence was found to be 13.1%. [46] These results support the 
theory that HIV status may be a risk factor for appendicitis. [26,40,41]
The mean age was significantly higher in the HIV+ group than in the seronegative 
patients (29.3 vs. 20.3 years). This finding is echoed in both papers emanating from 
Africa, [3,46] which suggest that the HIV+ patient develops appendicitis at a more 
advanced age. A large study that interrogated the Nationwide Inpatient Sample (NIS) 
in the US also showed that AIDS patients undergoing appendectomy were 
significantly older than the control group. [31] Crum-Cianflone and colleagues [40] 
propose that biological and epidemiological factors account for this observation. HIV 
seropositivity imparts an increased risk of developing appendicitis because the fragile 
vasculature of the appendix is more predisposed to disease. Furthermore, 
opportunistic infections and IRIS secondary to HAART render HIV+ patients more 
prone to developing appendicitis. Most importantly in South Africa, HIV 
seroconversion tends to occur in early adulthood and predominantly affects the young. 
The South African National HIV prevalence, Incidence and Behaviour Survey in 2012 
showed that 25.2% adults belonging to the 25 to 49-year age group were HIV+; these 
data mirror the prevalence of HIV seen in patients with appendicitis. [3] 
In this study, the mean CD4+ count was 260 cells/μL and was recorded in 81% (13 
patients) of the HIV+ cohort. Because of the small subgroup numbers, it was not 
statistically feasible to correlate the CD4+ count with appendiceal perforation or post-
operative morbidity and mortality. A Viral Load (VL) was not routinely performed 
for budgetary reasons. In our setting, the VL is used to gauge therapeutic response to 
HAART and determine the presence of viral resistance. Establishing whether CD4+ 
count or VL should be routinely done in the HIV+ undergoing abdominal surgery has 
been a futile endeavour so far. We remain unconvinced of their use as surgical 
prognosticators since the literature comprises mainly of retrospective series with 
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conflicting results. [48-51] Some studies show higher morbidity with advanced clinical 
stages of the disease [52,53], whilst others conclude there is no difference. [50] It is well 
established that CD4+ helper T lymphocytes are important role players in the initial 
infection with the virus and play a vital role in wound healing. [54-56] This is why the 
CD4+ count is regarded by many as a predictor of outcome in HIV+ patients 
undergoing abdominal surgery. 
Some surgeons will still advocate for a CD4+ count >200 cells/l before operating on 
an infected patient. [48-50] In a prospective cohort study, ČaČala et al [51] showed that 
HIV status did not influence the outcome of general surgical procedures, and CD4+ 
count was not a prognosticator of total hospital stay, hospital mortality and severity of 
post-operative sepsis. However, in a recent large retrospective study investigating the 
effects of HIV status on the outcomes of surgical sepsis, Green et al [6] determined 
that there was a significantly higher mortality of 60% in patients who had a CD4+ 
count <200 cells/l versus 2% in the CD4+ count >200 cells/l group. In emergency 
surgery patients, a lower CD4+ count is associated with increased post-operative 
septic complications and longer hospital stay [43,48,49]. Xia et al [49] have gone on to 
further suggest that a CD4/CD8 ratio 0.15 is a useful predictor of post-operative 
sepsis in HIV+ patients undergoing major abdominal surgery.  
Delayed presentation to hospital occurred more frequently in the HIV+ patient cohort 
(3.94 vs. 2.57 days, P = 0.03). Failure to mount an immune response can manifest 
clinically by the absence of pyrexia and abdominal signs in early appendicitis. 
Localised right iliac fossa tenderness is not common in those infected with the virus [3]
and pre-operative leukocytosis is also less frequently observed. [46]
Many have suggested that the absence of these clinical signs, symptoms and 
laboratory findings contribute to the delay in hospital presentation, and the subsequent 
higher morbidity seen in HIV+ patients. Although the delay in presentation is well 
documented in this study, there were no difference in the clinical signs and symptoms 
exhibited by both patient groups.  
A recent systematic review conducted by Yang et al confirmed that appendicitis 
trends in South Africa are consistent with those seen in other newly industrialised 
countries. [57] However, appendicitis in South Africa has a far more serious clinical 
course when compared to developed countries, mainly because of longer delays in 
getting definitive surgical care. A high perforation rate of 36% and the need for 
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laparotomy in 18% to 60% of patients drive the high post-operative morbidity seen in 
these patients. [58] Up to 30% of patients will require Temporary Abdominal Closure 
(TAC) at their initial surgery because of four quadrant peritonitis, diffuse soiling of 
the abdomen and the need for relook laparotomies. Furthermore, 11% of patients will 
require admission to the Intensive Care Unit and 29% will require a second surgical 
intervention. [58] The laparotomy rate was higher in HIV+ patients (72.2% vs. 41.3%, 
P=0.03). Previous authors have ascribed this operative approach to the high rate of 
perforation and peritonitis, that occur due to the delay in presentation of these 
patients. [3,46] Most studies show that there is a higher incidence of post-operative 
complications and a lengthier hospital stay in the HIV+ group. [3,31,46] The morbidity 
relates predominantly to Surgical Site Infections, and is reduced with a laparoscopic 
approach. [31,47] The post-operative morbidity was higher in those infected with the 
virus (38.9% vs. 14.7%, P=0.03) in this study. SSI was the most common 
complication and septic shock was documented in a single patient. These findings are 
in keeping with previous studies that have investigated the effect of HIV on 
appendicitis. [3,46,31,47] In spite of these correlations, the impact of the HIV pandemic 
on surgical outcomes remains controversial; there are no prospective trials in the 
current literature and most retrospective studies are small and yielded conflicting 
results. [59-61] Early reports showed high mortality rates of 55% to 70% in AIDS 
patients undergoing emergency surgery. Based on the data available then, surgeons 
tended to be more conservative with HIV+ patients and avoided major surgical 
interventions. [50] However, there is now emerging evidence to suggest that the post-
operative morbidity and mortality in HIV+ patients compare favourably to HIV- 
patients, and that the standard surgical therapy should be equally afforded to both 
groups. [62,63]  
The principal flaw in the old studies was that most investigators failed to make a clear 
distinction between the surgical risk in HIV+ patients and AIDS patients. This 
argument has been well substantiated by Harris et al [29], who showed that when an 
AIDS-related condition is the primary indication for emergency surgery, the 
morbidity increases by four-fold and the mortality rises from 15% to 44%. However, 
more than two thirds of HIV+ patients who undergo abdominal surgery for an acute 
abdomen do not have any AIDS-related pathology. Therefore, the data cannot be 
applied to all HIV+ patients. 
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There was a single mortality in the HIV+ group. This was a 26-year-old pregnant 
woman who had a laparotomy for perforated appendicitis in the presence of 
abdominal TB. She was ventilated for one day in the ICU and demised of septic 
shock. The two deaths in the HIV- were also attributed to septic shock secondary to 
diffuse peritonitis. The mortality was similar in both patient cohorts. Whether HIV+ 
patients undergoing emergency abdominal surgery are at risk for increased mortality 
is still highly debatable. A careful literature search yielded contradictory data with 
regards to mortality. [64-71] There is some data to suggest that anorectal procedures are 
predisposed to poorer outcomes, and late mortality is related to the progression of 
HIV infection rather than the primary surgical pathology. [64,70,71] Irrespective of 
aetiology, GIT bleeding is another poor prognosticator of both in-hospital and long-
term mortality.  [65,66]  
Following major abdominal surgery, HIV+ patients should be considered for ICU 
care. In a South African study, Bhagwanjee et al [62] showed no increase in the ICU 
and total hospital stay, albeit the higher incidence of septic shock in HIV+ patients. 
Predictors of long-term survival after ICU admission include mechanical ventilation 
and albumin levels. [63] 
Post appendectomy, the HIV+ patients stayed longer in hospital (7.28 vs. 5.95 days, 
P=0.004); an observation made by two large national database studies previously. 
[31,47] The length of hospital stay in this study relates mainly to the post-operative 
complications of SSIs and persistent pyrexia. Cases of SSIs were managed in hospital 
until all wounds were fully consolidated. This is mainly because of the geography of 
the Northern Cape province; a large number of our patients come from rural areas and 
access to healthcare facilities can be difficult.  
A prolonged post-operative pyrexia was noted in two HIV+ patients; the septic work- 
up was negative in both. It is interesting to note that previous authors have made 
similar observations but could not assign a specific aetiology to them. [40,46]  
Conclusion 
This retrospective study investigated the effect of HIV status on the surgical outcomes 
of appendectomy in the Northern Cape Province of South Africa. The HIV prevalence 
in those undergoing appendectomy in South Africa is not negligible. Furthermore, 
these patients present in a delayed fashion to hospital and require more extensive 
surgery than their seronegative counterparts. Findings of higher post-operative 
complication rates in those infected in the virus are in keeping with previous reports. 
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The effect of CD4+ count, VL and Clinical Stage on surgical outcome is still 
controversial. It is vital to understand that this study was conducted in a single 
province of South Africa where the HIV prevalence is 7.4%, and only provides a 
snapshot of the effect of HIV on a common GIT surgical emergency. The HIV 
infection rate in appendicitis patients was nearly double the population rate at 13.4%, 
suggesting that HIV infection might be a risk for developing acute appendicitis. 
Although the current data does provide some direction regarding the issue, there is 
need for a large multi-centre prospective study in Sub-Saharan Africa to investigate 
the effect of HIV status on the surgical outcomes of appendicitis.  
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Table 1: Prevalence of chronic medical conditions in South Africa [20-24] 
Chronic Medical Condition Prevalence in South Africa (%) 
Hypertension 30.4 
HIV 12.2 
Asthma 8.1 
Diabetes 7.0 
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Table 2: Comorbid conditions in patients recruited for South African Surgical 
Outcomes Study [25] 
Comorbid disease N (%) 
HIV/AIDS 509 (13.2) 
Chronic Obstructive Pulmonary Disease/Asthma 240 (6.2) 
Diabetes 225 (5.8) 
Coronary Artery Disease 160 (4.1) 
Congestive Cardiac Failure 55 (1.4) 
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Table 3: Studies addressing surgical outcomes of appendicitis in HIV+ and HIV- patients 
Study Year Country 
Period 
(years) 
Number of 
patients 
Significant Study findings 
Bova et al [45] 1998 Australia 10 
HIV- (60) 
HIV+ (26) 
Significant delay in presentation to hospital in the HIV+ group 
Higher post-operative morbidity rate in HIV+ group 
Giiti et al [46] 2010 Tanzania 1 
HIV- (173) 
HIV+ (26) 
HIV+ patients older and have less leukocytosis 
Peritonitis more common in HIV+ group with increased rates of  
Surgical Site Infection and lengthier hospital stay 
Masoomi et al 
[47]
2015 US 3 
HIV- (572444) 
HIV+ (800) 
Patients with AIDS had lengthier hospital stay, higher post-operative 
complication and mortality rates 
Laparoscopic appendectomy in AIDS patients has lower morbidity, 
mortality and shorter hospital stay compared to open appendectomy 
Kitaoka et al [43] 2015 Japan 6 
HIV- (212) 
HIV+ (6) 
CD4+ count lower in HIV+ patients with complicated appendicitis 
Gigabhoy et al 
[3]
2016 
South 
Africa 
1 
HIV- (36) 
HIV+ (14) 
Higher laparotomy rate in HIV+ patients 
Smith et al [31] 2016 US 8 
HIV- (337514) 
HIV+ (794) 
Longer and more expensive hospital stay in AIDS patients 
Higher risk of post-operative infections in AIDS patients 
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Table 4. Demographic and Clinical Characteristics of patients undergoing 
appendectomy during study 
Demographic / Clinical Characteristics 
HIV+ 
(n=18) 
HIV- 
(n=116) 
P Value 
Gender (number) 
    Male 
    Female 
11 
7 
75         
41 
- 
Age (years) 
    Mean 
    Range 
29.3 
13-30
20.3 
4-64
0.002 
Delay (days) 
    Mean 
    Range 
3.94 
0-14
2.57 
0-15
0.003 
ICU Stay (days) 
    Mean  
    Range 
1 
1-1
3 
3-6
0.71 
Total Hospital Stay (days) 
    Mean  
    Range 
Mortality 
    Number 
    Rate ( %) 
7.28 
3-19
1 
5.56 
5.95 
1-53
2 
1.72 
0.004 
> 0.05
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Table 5. Individual clinical and haematological characteristics in HIV- and HIV+ 
patients 
Clinical and Laboratory Parameters HIV+ (n=18) 
N (%) 
HIV- (n=116) 
N (%) 
P Value 
Symptoms 
> 0.05
Migratory Right Iliac Fossa Pain 67 (58) 13 (72) 
 Nausea / Vomiting 95 (83) 16 (89) 
Anorexia 96 (83) 15 (83) 
Signs 
Right lower quadrant pain 108 (94) 17 (94) 
Rebound tenderness 86 (75) 16 (89) 
Elevated temperature 64 (56) 11 (61) 
Laboratory Findings 
Leucocytosis 93 (81) 11 (61) 
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Table 6. Surgical approaches in HIV+ and HIV- patient cohorts 
Surgical Approach 
HIV+ (n = 18) 
Number (%) 
HIV- (n = 116) 
Number (%) 
Minor 
   McBurney Incision  
   Lanz Incision 
   Laparoscopic  
   Laparoscopic converted to McBurney Incision 
Total 
4 (22.2) 
0 
1 (5.56) 
0 
5 (27.8) 
44 (37.9) 
17 (14.7) 
6 (5.17) 
1(0.862) 
68 (58.7) 
Major 
   Laparotomy  
   McBurney Incision converted to laparotomy 
   Lanz Incision converted to laparotomy  
   Laparoscopic converted to laparotomy 
Total 
11 (61.1) 
0 
0 
2 (11.1) 
13 (72.2) 
41 (35.3) 
5 (4.31) 
2 (1.72) 
0 
48 (41.3) 
P Value 0.03 
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Table 7. Complications documented in HIV- and HIV+ patient cohorts 
HIV Status Post-operative Complications Number of Complications (%) 
HIV+ 
(n=18) 
Surgical Site Infection  
Persistent Post-operative Pyrexia 
Intraabdominal Abscess  
Septic Shock 
Morbidity Rate 
3 
2 
1 
1 
7/18 (38.9 %) 
HIV- 
(n=116) 
Surgical Site Infection  
Intraabdominal Abscess 
Ileus 
Septic Shock  
Nosocomial Pneumonia 
Morbidity Rate 
9 
3 
2 
2 
1 
17/116 (14.7 %) 
P Value 0.03 
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PROTOCOL AND ETHICS APPROVAL: 
 
A STUDY COMPARING OUTCOMES OF APPENDECTOMY BETWEEN 
HIV-INFECTED AND HIV-NEGATIVE PATIENTS 
 
SYNOPSIS 
 
Kimberley Hospital is a large regional facility, providing surgical services to the 
entirety of the Northern Cape. Appendicitis remains the most common surgical 
pathology encountered by surgical centres worldwide. In South Africa, the 
presentation and the outcome of this disease has been influenced by delayed 
presentation and comorbidities. Fatalities are not infrequent, and comorbidities are 
often the culprit factors. The effect of HIV/AIDS on the surgical management of 
appendicitis has not been described before. 
 
 
Research setting: 
 
This chart review will be conducted in the Surgical Unit at Kimberley Hospital. 
Folders of patients who have undergone surgery for appendicitis will be drawn from 
the department surgical log for the period February 2010 to February 2011.  
 
Study Aim:  
 
The aim of this retrospective study is to describe and compare the outcomes of 
appendectomy between HIV-infected and HIV-negative patients from a one a large 
regional surgical unit.  
 
Study Objectives:  
 
1. To describe the demographics of patients presenting to a large regional 
surgical unit with clinical features of appendicitis 
2. To describe the history and presentation of such patients on arrival to hospital  
3. To detail the associated comorbidities in these patients  
4. To evaluate the short and long-term morbidity of admitted patients  
5. To compare the outcomes in HIV-infected and HIV-negative patients 
 
Study Design:  
 
This will be a review of all patients who have undergone surgery for appendicitis at 
Kimberley Hospital for the period February 2010 to February 2011. Since this is a 
chart review, only patients who have been tested for HIV at some point will be 
included. Test results will be drawn from the patient files.  
 
Inclusion / Exclusion Criteria:  
 
All patients who underwent surgery for a clinical diagnosis of appendicitis at 
Kimberley Hospital and who were tested for HIV. 
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Study Participants:  
 
Study participants will be identified from the surgical log at the Department of 
General Surgery at Kimberley Hospital.   
 
Protection of Study Participants:  
 
Study parameters will be drawn from retrieved patient files and entered into data 
collection sheets, which will be kept with the lead investigator. At no point will 
photos of patients be included in this study. All data collection sheets will be 
destroyed at the end of the study.  
 
Expected Benefits:  
 
It is expected that at the end of the study, we will be able to describe the full range of 
presentations for patients with appendicitis in the Northern Cape. This should allow 
us to establish whether HIV status affects the outcomes of appendectomy.  
 
RESEARCH PROTOCOL  
 
Purpose of study: 
 
The purpose of this study is to describe our experience with the management of 
patients with appendicitis at Kimberley Hospital. Our objectives will be to:  
 
1. To evaluate the presentation of appendicitis at Kimberley Regional Hospital  
2. To describe the demographics of these patients  
3. To describe the presentation of such patients on arrival to hospital  
4. To detail the associated comorbidities in these patients  
5. To evaluate the short and long-term morbidity of admitted patients  
6. To compare outcomes in HIV-infected and HIV-negative patients 
 
 
Background:  
 
The Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome 
(HIV/AIDS) pandemic has added a new dimension to the management and surgical 
outcomes of acute appendicitis.1-7 A rising incidence of this common gastrointestinal 
surgical emergency in the developing world has been attributed to the HIV/AIDS 
crisis in Sub-Saharan Africa.2 HIV-infected (HIV+) patients are more susceptible to 
developing appendicitis than the general population. Postulates for this include a high 
incidence of opportunistic infections, a dampened immune response and the 
emergence of appendicitis as a manifestation of the Immune Reconstitution 
Inflammatory Response (IRIS), with the advent of Highly Active Antiretroviral 
Therapy (HAART).2,8-9 
An estimated 10 to 15 % of HIV+ patients will experience severe abdominal pain 
during their illness. The diagnosis of appendicitis in these patients is challenging. 
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Opportunistic infections including Cytomegalovirus and Tuberculosis, and AIDS-
related malignancies such as Kaposi`s Sarcoma and lymphoma will frequently mimic 
the clinical presentation of acute appendicitis. Whilst an appendicectomy will confirm 
the diagnoses of these related infections and malignancies, surgical outcomes of 
appendicectomy in HIV+ patients have been associated with high rates of morbidity 
and mortality.1,2,4,8 
Despite an estimated national HIV prevalence of 12.2 %, there are no published 
reports describing the surgical outcomes of acute appendicitis in the HIV-infected 
population in South Africa.10 Studies comparing surgical outcomes in HIV-infected 
and HIV-positive patients are few and have emanated from Northern America and 
Europe.9 Thus, the aim of this study is to describe and compare the surgical outcomes 
of acute appendicitis in HIV+ and HIV-negative (HIV-) patients following 
appendectomy. 
 
Methods:  
 
This will be a review of all patients treated at Kimberley Hospital for appendicitis 
from February 2010 to February 2011. Study participants will be identified from the 
Department of Surgery’s Surgical Log. Study parameters will be drawn from 
retrieved patient files and entered into data collection sheets, which will be kept with 
the lead investigator only at all times. At no point will photos of patients be included 
in this study. All data collection sheets will be destroyed at the end of the study. Data 
will be entered into Microsoft Excel and Descriptive Statistics used to compute the 
results.  
 
Potential Benefits: 
 
It is expected that at the end of the study, we will be able to describe the full range of 
presentations for patients with appendicitis in the Northern Cape. This should allow 
us to establish whether HIV has an effect on the surgical outcomes of appendicitis.  
 
 
Informed Consent Process: 
 
No additional consent will be required. All patients grant consent according to 
standard procedures at Kimberley Hospital.  
 
 
Privacy and Confidentiality: 
 
At no times will patient names be documented during the study; only file numbers 
will be used. At no point will photos of patients be included in this study. All data 
collection sheets will be destroyed at the end of the study.  
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DATA COLLECTION SHEET 
 
DEMOGRAPHICS 
Folder no: 
Age: 
Gender: 
Date of onset of symptoms: 
Date of admission: 
Date of discharge: 
ICU Stay: 
Ward: 
 
HIV Data 
HIV Status: 
CD4 count: 
WHO Stage: 
HAART: Yes/No 
Bactrim prophylaxis: Yes/No 
 
COMORBIDITIES 
 
VITALS ON ADMISSION      
 
BP:               P:                T: 
 
INVESTIGATIONS 
WCC: 
AXR:  
CXR:  
U/S: 
CT: 
ESR: 
CRP: 
Urine Dipstix: 
Sputum: 
 
OPERATIVE APPROACH: 
 
OPERATIVE FINDINGS: 
 
HISTOLOGY CODE:  
 
PUS SWAB: 
 
OUTCOME (e.g. Uneventful, wound sepsis, death):  
 
LONG TERM FOLLOW UP (e.g. Clinic Visit at 6 weeks):  
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